Erlotinib Pretreatment Improves Photodynamic Therapy of Non–Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms

SM Gallagher-Colombo, J Miller, KA Cengel, ME Putt… - Cancer research, 2015 - AACR
Aberrant expression of the epidermal growth factor receptor (EGFR) is a common
characteristic of many cancers, including non–small cell lung carcinoma (NSCLC), head and …

Erlotinib Pretreatment Improves Photodynamic Therapy of Non-Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms

SM Gallagher-Colombo, J Miller… - Cancer …, 2015 - pubmed.ncbi.nlm.nih.gov
Aberrant expression of the epidermal growth factor receptor (EGFR) is a common
characteristic of many cancers, including non-small cell lung carcinoma (NSCLC), head and …

[PDF][PDF] Erlotinib Pretreatment Improves Photodynamic Therapy of Non–Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms

SM Gallagher-Colombo, J Miller, KA Cengel… - Cancer Res, 2015 - researchgate.net
Aberrant expression of the epidermal growth factor receptor (EGFR) is a common
characteristic of many cancers, including non–small cell lung carcinoma (NSCLC), head and …

[HTML][HTML] Erlotinib pretreatment improves photodynamic therapy of non-small cell lung carcinoma xenografts via multiple mechanisms

SM Gallagher-Colombo, J Miller, KA Cengel… - Cancer …, 2015 - ncbi.nlm.nih.gov
Aberrant expression of the epidermal growth factor receptor (EGFR) is a common
characteristic of many cancers including non-small cell lung carcinoma (NSCLC), head and …

Erlotinib Pretreatment Improves Photodynamic Therapy of Non–Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms

SM Gallagher-Colombo, J Miller, KA Cengel, ME Putt… - Cancer …, 2015 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Aberrant expression of the epidermal growth
factor receptor (EGFR) is a common characteristic of many cancers, including non–small cell …

Erlotinib Pretreatment Improves Photodynamic Therapy of Non-Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms.

SM Gallagher-Colombo, J Miller, KA Cengel… - Cancer …, 2015 - europepmc.org
Aberrant expression of the epidermal growth factor receptor (EGFR) is a common
characteristic of many cancers including non-small cell lung carcinoma (NSCLC), head and …

Erlotinib Pretreatment Improves Photodynamic Therapy of Non-Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms.

SM Gallagher-Colombo, J Miller, KA Cengel… - Cancer …, 2015 - europepmc.org
Aberrant expression of the epidermal growth factor receptor (EGFR) is a common
characteristic of many cancers including non-small cell lung carcinoma (NSCLC), head and …